Variant report
Variant | rs16842321 |
---|---|
Chromosome Location | chr1:224046104-224046105 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | POLR2A | chr1:224045818-224046574 | K562 | blood: | n/a | n/a |
2 | ZNF263 | chr1:224045994-224046433 | HEK293-T-REx | kidney: | n/a | chr1:224046246-224046255 |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:224030773..224035996-chr1:224045738..224052159,10 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PHBP11 | TF binding region |
ENSG00000143514 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1003061 | 0.89[ASN][1000 genomes] |
rs1037952 | 0.84[EUR][1000 genomes] |
rs1153927 | 0.93[ASN][1000 genomes] |
rs1153929 | 0.90[ASN][1000 genomes] |
rs1153930 | 1.00[CEU][hapmap];1.00[CHD][hapmap];0.87[GIH][hapmap];1.00[JPT][hapmap];0.90[ASN][1000 genomes] |
rs1153933 | 1.00[CEU][hapmap];1.00[CHD][hapmap];0.87[GIH][hapmap];1.00[JPT][hapmap];0.90[ASN][1000 genomes] |
rs1153934 | 0.90[ASN][1000 genomes] |
rs1153936 | 0.85[CEU][hapmap];1.00[JPT][hapmap];0.88[ASN][1000 genomes] |
rs1153943 | 1.00[CEU][hapmap] |
rs1153947 | 1.00[CEU][hapmap];0.96[CHD][hapmap];0.94[JPT][hapmap];0.87[ASN][1000 genomes] |
rs1153949 | 0.87[ASN][1000 genomes] |
rs1153971 | 1.00[CEU][hapmap];1.00[CHD][hapmap];0.87[GIH][hapmap];0.94[JPT][hapmap];0.91[ASN][1000 genomes] |
rs1153973 | 0.93[ASN][1000 genomes] |
rs1222120 | 1.00[CEU][hapmap];1.00[JPT][hapmap];0.88[ASN][1000 genomes] |
rs1222121 | 1.00[CEU][hapmap];1.00[CHD][hapmap];0.87[GIH][hapmap];1.00[JPT][hapmap];0.86[YRI][hapmap];0.88[ASN][1000 genomes] |
rs1222124 | 1.00[CEU][hapmap];1.00[JPT][hapmap];0.93[ASN][1000 genomes] |
rs1222128 | 1.00[CEU][hapmap];1.00[JPT][hapmap];0.93[ASN][1000 genomes] |
rs1222146 | 0.87[ASN][1000 genomes] |
rs1621129 | 0.84[ASN][1000 genomes] |
rs1629850 | 1.00[CEU][hapmap];0.84[MKK][hapmap] |
rs16842270 | 0.87[AFR][1000 genomes];0.82[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs16842294 | 1.00[CEU][hapmap];0.93[JPT][hapmap];0.97[ASN][1000 genomes] |
rs1981171 | 0.88[AFR][1000 genomes];0.83[AMR][1000 genomes];0.94[ASN][1000 genomes] |
rs1982610 | 0.97[ASN][1000 genomes] |
rs1982612 | 1.00[CEU][hapmap];1.00[CHD][hapmap];0.87[GIH][hapmap];1.00[JPT][hapmap];0.97[ASN][1000 genomes] |
rs1982613 | 0.97[ASN][1000 genomes] |
rs2242188 | 0.91[ASW][hapmap];1.00[CEU][hapmap];0.96[CHD][hapmap];0.85[GIH][hapmap];1.00[JPT][hapmap];0.93[LWK][hapmap];0.87[MKK][hapmap];0.90[YRI][hapmap];0.87[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs28370172 | 0.82[AFR][1000 genomes];0.87[ASN][1000 genomes] |
rs3738370 | 1.00[CEU][hapmap];1.00[CHD][hapmap];0.87[GIH][hapmap];1.00[JPT][hapmap];0.85[MEX][hapmap];0.95[ASN][1000 genomes] |
rs3767709 | 1.00[CEU][hapmap];1.00[JPT][hapmap];0.90[YRI][hapmap];0.90[AFR][1000 genomes];0.82[AMR][1000 genomes];0.93[ASN][1000 genomes] |
rs4653457 | 1.00[CEU][hapmap];0.96[CHD][hapmap];1.00[JPT][hapmap];0.87[ASN][1000 genomes] |
rs56329085 | 0.90[AFR][1000 genomes];0.92[AMR][1000 genomes];0.99[ASN][1000 genomes] |
rs56918361 | 0.95[ASN][1000 genomes] |
rs59104475 | 0.92[AFR][1000 genomes];0.90[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs59196624 | 0.87[AFR][1000 genomes];0.82[AMR][1000 genomes];0.88[ASN][1000 genomes] |
rs60131749 | 0.90[AFR][1000 genomes];0.83[AMR][1000 genomes];0.95[ASN][1000 genomes] |
rs60164080 | 0.87[AFR][1000 genomes];0.82[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs60596974 | 0.84[AFR][1000 genomes];0.95[EUR][1000 genomes] |
rs60739082 | 0.86[ASN][1000 genomes] |
rs6604726 | 0.86[ASN][1000 genomes] |
rs6661816 | 0.88[ASN][1000 genomes] |
rs6675712 | 0.82[CEU][hapmap];0.83[JPT][hapmap];0.86[YRI][hapmap];0.82[AFR][1000 genomes];0.87[ASN][1000 genomes] |
rs6694214 | 0.87[AFR][1000 genomes];0.87[ASN][1000 genomes] |
rs6703817 | 0.84[EUR][1000 genomes] |
rs72749588 | 0.90[AFR][1000 genomes];0.98[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs72749591 | 0.92[EUR][1000 genomes] |
rs72749597 | 0.90[EUR][1000 genomes] |
rs72749599 | 0.90[EUR][1000 genomes] |
rs737066 | 0.85[CEU][hapmap];0.86[MKK][hapmap] |
rs7536779 | 0.95[ASN][1000 genomes] |
rs898878 | 0.88[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | esv3361888 | chr1:223725597-224114846 | Enhancers Strong transcription Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 34 gene(s) | inside rSNPs | diseases |
2 | esv34082 | chr1:223851018-224144509 | Enhancers Genic enhancers Active TSS Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
3 | nsv1008800 | chr1:223904653-224061032 | Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 13 gene(s) | inside rSNPs | diseases |
4 | esv2757772 | chr1:223935220-224363163 | Genic enhancers ZNF genes & repeats Weak transcription Flanking Active TSS Active TSS Strong transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 36 gene(s) | inside rSNPs | diseases |
5 | esv2759000 | chr1:223935220-224363163 | Enhancers Weak transcription Genic enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 36 gene(s) | inside rSNPs | diseases |
6 | nsv945311 | chr1:224043754-224046221 | Enhancers Weak transcription | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:224041800-224047000 | Weak transcription | NHEK | skin |
2 | chr1:224041800-224047200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr1:224044800-224047800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr1:224044800-224051800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr1:224045800-224046400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr1:224046000-224046400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr1:224046000-224048600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |